Wondering about the differences between BPC-157 capsules and injections?
If so, then you are in luck, as this expert guide has got you covered.
Below, our team of experts will explain all you need to know about the best BPC-157 administration methods, as well as the emerging therapeutic benefits and safety of this popular research peptide. We will cover:
- What is BPC-157?
- BPC-157 capsules
- Oral BPC-157 versus injections
- Are BPC-157 injections better?
- BPC-157 benefits
- BPC-157 safety
Read on to become well-versed in BPC-157, including its chemical features, therapeutic potential, and best routes of administration according to the latest peer-reviewed studies.
Buy BPC-157 + TB-500 Capsules from our #1 recommended vendor...
Disclaimer: Peptides.org contains information about products that are intended for laboratory and research use only, unless otherwise explicitly stated. This information, including any referenced scientific or clinical research, is made available for educational purposes only. Peptides.org makes every effort to ensure that any information it shares complies with national and international standards for clinical trial information and is committed to the timely disclosure of the design and results of all interventional clinical studies for innovative treatments publicly available or that may be made available. However, research is not considered conclusive. Peptides.org makes no claims that any products referenced can cure, treat or prevent any conditions, including any conditions referenced on its website or in print materials.
What is BPC-157?
BPC-157 (Body Protection Compound-157), also called bepecin, is a synthetic gastro peptide that is currently under close review for its evidenced therapeutic benefits.
A pentadecapeptide, BPC-157 is derived from Body Protection Compound (BPC), an endogenous gastric protein that is produced in the human digestive tract. BPC maintains healthy digestive function and GI lining and has further been proven to enhance cellular repair, angiogenesis, tissue growth, and inflammatory response [1, 2, 3].
BPC-157 is modified for greater stability than its parent compound and is shown to have systemic effects without the need for a carrier agent. As a gastric protein, BPC primarily acts to protect and heal the lining of the gastrointestinal tract. However, its synthetic derivative has been shown in clinical studies to be of benefit to other organ systems in small doses. This is due primarily to its twofold increase in fibroblast proliferation and vascular tissue growth.
Known benefits of BPC-157 include faster healing in multiple types of tissue, such as hepatic, vascular, and nervous, suggesting its potential to treat neurological and cardiovascular diseases. It is further evidenced to boost growth and healing in muscle, tendon, and bone tissue. Due to its potent antioxidant activity, it combats oxidative stress in both the gastrointestinal tract and throughout the body, indicating further promise as a treatment for inflammatory diseases [2, 3, 4, 5, 6].
Research and Development
BPC-157 was originally developed over 20 years ago as an anti-ulcer agent due to its marked cytoprotective benefits. However, it has not received approval as a medical product from the US Food and Drug Administration (FDA), and studies on its use in humans are lacking. Nonetheless, extant clinical trials and vast research in animal models indicate a positive safety profile [1–7].
It is among several popular research peptides that are known for their regenerative effects. TB-500 is another synthetic peptide known to impart angiogenic and reparative benefits, although via distinct mechanisms .
While BPC-157 can be injected or orally consumed, the latter route may be associated with more targeted effects on the GI tract. However, because the oral bioavailability of standard BPC-157 is limited, it is often delivered via subcutaneous injection. In response, scientists have recently synthesized a novel form of BPC-157 with greater stability to maintain potency and therapeutic potential with oral consumption, as detailed below .
BPC-157 Capsules | What Researchers MUST Know
Research into the healing effects of BPC-157 indicates that oral administration may have therapeutic advantages in certain contexts, such as the treatment of ischemic colitis and the fortification of the gut-brain axis. With increased stability, oral preparations also have extended durations of action, further increasing their therapeutic potential [9, 10, 11, 12].
The most exciting advances in this regard include the following capsular formulas from the leading peptide source, Peptide Sciences, featuring stable, orally active BPC-157 combined with other compounds for a synergistic effect.
Repair and Recovery Formula
This novel capsule formula features BPC-157 in arginate form, which is more stable than the standard acetate salt form of BPC-157. This stabilized form resists gastric acids to enable oral bioavailability while maintaining the therapeutic function of the original peptide .
The innovative blend also includes a fragment of the healing and anti-inflammatory peptide thymosin beta-4 (TB4), otherwise known as TB-500. A synthetic analog of the endogenous 43 amino-acid peptide of the same name, TB4 stimulates tissue growth and repair while improving immune and inflammatory responses. The fragmentary form included in this formula presents greater bioavailability, more easily absorbed into the GI tract due to its smaller size [13, 14, 15].
Influencing healing through distinct biological mechanisms, BPC-157 and TB4 may combine for synergistic regenerative effects. For example, while TB4 has been shown to stimulate fibroblast migration, BPC-157 evidently improves fibroblast function. Both are shown to broadly promote angiogenesis, combat oxidative stress, and stimulate cell migration [3, 9, 13].
Surprisingly, little research has been done on the combined application of these two healing compounds. However, in light of their respective benefits, clinicians posit that the complementary blend could have a particular impact in improving injury repair as well as the treatment of cardiovascular, neurological, and inflammatory diseases.
Gut Inflammation Formula
This formula features a blend of three powerful anti-inflammatory compounds in addition to the orally bioavailable peptide BPC-157 arginate for targeted treatment of the GI tract. Each of these ingredients is naturally occurring and evidenced to reduce GI inflammation via distinct pathways.
KPV is a synthetic analog of alpha-melanocyte-stimulating hormone. It has been shown along with the triglyceride tributyrin to regulate cytokine levels, eliciting strong anti-inflammatory effects. Both are shown in animal models to be particularly adept at suppressing TNF-alpha, a cytokine that is heavily linked with inflammatory bowel disease [16, 17, 18].
Meanwhile, BPC-157 protects the GI lining while PEA, an organic fatty acid, is shown in animal studies to attenuate inflammation globally via multiple mechanisms. These include modulations in gene expression, stimulation of the endocannabinoid system, and action on the central nervous system. PEA is known for its anti-nociceptive (pain-relieving) effects [2, 19, 20, 21].
Clinicians are confident in the healing effects of this blend on the GI tract. Each component is uniquely beneficial, and their pathways are potentially synergistic. The combination may reduce gut inflammation on multiple levels, including systemically, via cytokine signaling, and through modulation of the intestinal immune response. When combined with the gut-fortifying properties of BPC-157, this shows promise as a formidable treatment for diseases of the GI tract, including perianal fistulas. It may also boost wound healing throughout the body.
Oral BPC-157 vs. Injections
Although studies investigating BPC 157 have demonstrated therapeutic potential, most of these analyses have been performed in animal models. As such, substantial data on BPC-157 use in humans is currently lacking. However, a review of the available research offers insights into the preferred routes of BPC-157 administration.
The main methods of administration seen in animal studies are topical creams, injections, and oral consumption, as follows:
- In a 2001 study by Mikus et al. into the effect of BPC 157 on burn-wound healing and burn-gastric lesions in mice, researchers administered BPC-157 10μg or 10 ng/kg via injections or topically, at the burn, as a thin layer of cream (50μg of BPC 157 dissolved in 2ml of distilled water). They concluded that topical treatment at the defect site appeared to stimulate burn healing more effectively than injection .
- A 2003 study by Staresinic et al. found that BPC-157 accelerated the healing of transected rat Achilles tendons when applied topically (dissolved in saline) at a dose of 10 pg.,10 ng, or 10 pg .
- A 2009 rat study by Sever et al. administered BPC 157 (10mcg/kg or 10 ng/kg) orally, in drinking water (12 ml/rat/day) or intraperitoneally (once daily, first application 30 min following surgery to test its effects on short bowel syndrome in rats, observing the effectiveness of both forms of administration .
- A 2019 study by Perovic et al. found that BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats. Researchers administered a one-time intraperitoneal injection (BPC 157 (200 or 2 μg/kg) or 0.9% NaCl (5 ml/kg) 10 minutes after injury and concluded that all of the injured rats that received BPC-157 exhibited consistent clinical improvement .
These findings indicate that the effects of BPC-157 may in some cases be dependent on the dose and administration method, determined according to the therapeutic context.
For example, one animal study led researchers to conclude that the gastroprotective benefits of BPC-157 are dependent on the route of administration. Due to its stability, BPC-157 is shown to benefit the entire GI tract with oral administration. Significantly, phase I clinical trials on BPC-157 as a treatment for ulcerative colitis involved strictly oral administration [26, 27, 28].
However, another study on the effects of BPC-157 in treating urinary incontinence in mice indicated equal measures of effectiveness in both oral and intraperitoneal administration. Alternatively, in contexts such as the treatment of brain injuries and hypertension, injection has been the preferred method .
Thus, researchers are advised to familiarize themselves with the preferred administration methods in each therapeutic context.
Are BPC-157 Injections Better?
Traditionally, injection has been considered the most efficient route of administering peptide drugs. BPC-157 has been shown in animal studies to adhere to the metabolic process of standard peptide-based drugs, suggesting that injections are the most bioavailable route of BPC-157 administration [30, 31].
Breakthrough Oral Formulas
Clinicians have noted that the development of peptide therapeutics that are stable enough to withstand gastric juices could alter this dynamic. Researchers in 2008 proposed that the development of peptides with oral bioavailability of 30-50% would suffice to offset injection as the preferred ROA .
The breakthrough synthesis of BPC-157 arginate increased the 3% oral bioavailability of standard BPC-157 to greater than 90% in the arginate form. Although substantial studies on the clinical impact of the novel form are pending, this suggests that injection may not be the most efficient method when it comes to BPC-157 administration. As noted above, this may be particularly true of the peptide’s gastroprotective effects [9, 31].
The groundbreaking new BPC-157 formulas from Peptide Sciences offer great oral bioavailability at reasonable prices, an excellent resource for researchers interested in exploring this route of administration. Read on to learn more about these exciting products.
Where to Buy BPC-157 Capsules Online
The team of experts at Peptides.org has scanned the market to offer you our highest recommendation for BPC-157 capsules.
When it comes to peptide quality and vendor legitimacy, the top slot goes to these innovative formulas from the go-to supplier of the global scientific community, Peptide Sciences. They currently offer the following to forms of BPC-157 capsules:
- For injury recovery: Stable BPC-157 Arginate, Thymosin Beta-4 Fragment
- For gut healing: Stable BPC-157 Arginate, KPV, PEA, Tributyrin
Here are a few of the reasons why Peptide Sciences is the best peptide supplier on the web:
- USA-made Peptides: All products are made in partnership with WHO/GMP and ISO 9001:2008-approved manufacturers in the USA according to strict quality control guidelines. Domestic production allows Peptide Sciences to maintain low prices on top-quality peptides.
- Verified Quality: Peptide Sciences guarantees at least 99% purity levels on all peptides, verified with Certificates of Analysis (COAs) from third-party labs. This gives researchers complete insight into the quality of the peptides they are buying before they decide whether to place an order.
- Fair Prices: Peptide Science currently offers bottles of 60 BPC-157 Arginate, Thymosin Beta-4 Fragment capsules (250mcg) for just $320. Bottles of BPC-157 Arginate, KPV, PEA, Tributryn go for $325. These are reasonable prices for such advanced formulas and discounts are available on bulk purchases.
- Convenient Payment Methods: Researchers can pay with a variety of convenient payment methods including Cash App, Zelle, Venmo, credit card (via PayPal), and FLEX Payment (for pre-qualified customers only). Those wanting greater anonymity or security can pay with Bitcoin, Ether, or Electronic check, which is 100% encrypted, instant, safe, and secure.
- Fast, Reliable Worldwide Shipping: Shipping within the US takes just 2-3 days while researchers based internationally should receive their order in 7-10 days. Shipping fees are waived on all US orders above $200.
Visit Peptide Sciences today to purchase premium BPC-157 capsules from this leading brand!
BPC-157 has evidenced many exciting therapeutic effects in clinical studies. The most notable benefits are as follows:
Like its natural counterpart, BPC-157 is a powerful cytoprotective agent, stabilizing the GI lining and assisting in the prevention and repair of intestinal lesions. It is shown to effectively treat inflammatory bowel disease symptoms. Further, animal studies indicate that it may strengthen the gut-brain axis, improving feedback between the GI tract and the central nervous system to elicit systemic effects [2, 4, 11].
In animal models, BPC-157 has been shown to improve healing and tissue regeneration in GI tissues, as well as muscles, ligaments, skin, bone, and tendons. This is primarily affected by its stimulation of fibroblast proliferation [3, 11]
BPC-157 is proven in rat models to promote angiogenesis through the upregulation of endothelial growth factor. This not only enhances injury recovery but may improve cardiovascular health through circulatory increase and blood pressure stabilization [11, 32, 33].
Brain and Cognitive Health
BPC-157 is evidenced to have neuroprotective properties, attenuating damage due to strokes and central nervous system injuries while balancing neurotransmitters to combat symptoms of depression, Parkinson’s disease, and schizophrenia [2, 11, 34].
Reduces Drug Toxicity
Similarly, BPC-157 is shown to attenuate the toxicity and adverse effects of various drugs. Among these are alcohol, insulin, neuroleptics, and NSAIDs. Its protection extends from the nervous system to the liver, cardiovascular system, and GI tract [11, 34, 35].
The anti-inflammatory effects of BPC-157 are well-documented and have been observed in multiple types of tissue, such as the brain, liver, lungs, and GI tract [11, 32].
In addition to these notable benefits, emerging studies indicate BPC-157’s potential to combat signs of aging through collagen synthesis. It may also have analgesic properties [36, 37].
Is BPC-157 Safe?
While researchers have noted BPC-157's many benefits and lack of side effects, most BPC-157 studies to date have been performed on small rodent models rather than humans. Thus, there is little data from which to draw conclusions about its safety, especially regarding long-term use in humans .
However, extant human studies on BPC-157 as an anti-ulcer agent indicate a positive safety profile, with no toxicity reported .
Adverse reactions tend to be transient and mild, including :
- Injection site irritation
Because side effects are linked with low-quality peptides, researchers are strongly encouraged to source BPC-157 from reputable vendors. Although formal dosage guidelines have yet to be established, clinical studies offer useful insight into the safe and effective handling of BPC-157 and other research peptides.
Click here if you want to learn more about BPC-157 dosage!
BPC-157 Tablets | Verdict
With a range of documented benefits from GI and cognitive health to injury recovery, BPC-157 is of ongoing interest to leading clinical researchers. Until recently, injection was considered to be the most efficient form of BPC-157 administration. However, novel advances have led to more stable and orally bioavailable preparations that may augment this peptide’s already considerable therapeutic potential, especially as it affects the GI tract.
Researchers interested in exploring the burgeoning area of oral peptide administration should look no further than the innovative BPC-157 capsule formulas available from Peptide Sciences. These premium offerings feature not only top-quality BPC-157 but synergistic blends for enhanced benefits.
Buy BPC-157 + TB-500 Capsules from our #1 recommended vendor...